Loading...
Cencora, Inc.
COR•NYSE
HealthcareMedical - Distribution
$288.94
$0.53(0.18%)
Cencora, Inc. (COR) Financial Performance & Statements
Review Cencora, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
12.12%
↑ 12.12%
Operating Income Growth
-7.07%
↓ 7.07%
Net Income Growth
-13.53%
↓ 13.53%
Operating Cash Flow Growth
-10.91%
↓ 10.91%
Operating Margin
0.83%
↑ 0.83%
Gross Margin
3.29%
↑ 3.29%
Net Profit Margin
0.55%
↑ 0.55%
ROE
240.99%
↑ 240.99%
ROIC
14.40%
↑ 14.40%
Cencora, Inc. (COR) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Cencora, Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $81.49B | $79.05B | $74.24B | $68.41B |
| Cost of Revenue | $78.93B | $76.56B | $72.15B | $66.15B |
| Gross Profit | $2.56B | $2.49B | $2.09B | $2.27B |
| Gross Profit Ratio | $0.03 | $0.03 | $0.03 | $0.03 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.47B | $1.49B | $1.38B | $1.39B |
| Operating Expenses | $1.85B | $2.37B | $1.38B | $1.39B |
| Total Costs & Expenses | $80.40B | $78.92B | $73.54B | $67.54B |
| Interest Income | $33.25M | $0.00 | $27.61M | $12.68M |
| Interest Expense | $61.18M | $20.97M | $58.94M | $76.81M |
| Depreciation & Amortization | $278.49M | $277.04M | $278.93M | $271.73M |
| EBITDA | $961.04M | $423.19M | $966.20M | $821.95M |
| EBITDA Ratio | $0.01 | $0.005 | $0.01 | $0.01 |
| Operating Income | $706.25M | $126.64M | $703.37M | $877.48M |
| Operating Income Ratio | $0.009 | $0.002 | $0.009 | $0.01 |
| Other Income/Expenses (Net) | -$85.81M | -$1.46M | -$75.04M | -$86.19M |
| Income Before Tax | $620.45M | $125.18M | $628.33M | $467.07M |
| Income Before Tax Ratio | $0.008 | $0.002 | $0.008 | $0.007 |
| Income Tax Expense | $126.73M | $117.71M | $140.74M | $45.86M |
| Net Income | $488.60M | $3.38M | $483.46M | $420.77M |
| Net Income Ratio | $0.006 | $0.00 | $0.007 | $0.006 |
| EPS | $2.52 | $0.02 | $2.44 | $2.11 |
| Diluted EPS | $2.50 | $0.02 | $2.42 | $2.09 |
| Weighted Avg Shares Outstanding | $193.76M | $198.50M | $198.26M | $199.41M |
| Weighted Avg Shares Outstanding (Diluted) | $195.19M | $200.28M | $200.05M | $201.18M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan